Altimmune, Inc.ALTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-3.2%
5Y CAGR+22.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-3.2%/yr
vs +32.8%/yr prior
5Y CAGR
+22.0%/yr
Recent deceleration
Acceleration
-35.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $79.57M | -22.9% |
| 2024 | $103.19M | +7.1% |
| 2023 | $96.36M | +9.9% |
| 2022 | $87.67M | -13.5% |
| 2021 | $101.32M | +243.8% |
| 2020 | $29.47M | +8.1% |
| 2019 | $27.27M | -3.4% |
| 2018 | $28.22M | +74.6% |
| 2017 | $16.17M | -2.0% |
| 2016 | $16.49M | - |